<table id="table16" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 16. Mean Pharmacokinetic Parameters in Pediatric Patients With Epilepsy</caption>
<col align="left" span="1" valign="middle" width="40%"></col>
<col align="center" span="1" valign="middle" width="15%"></col>
<col align="center" span="1" valign="middle" width="15%"></col>
<col align="center" span="1" valign="middle" width="15%"></col>
<col align="center" span="1" valign="middle" width="15%"></col>
<tbody>
<tr>
<th colspan="1">Pediatric Study Population</th>
<th colspan="1">Number of Subjects</th>
<th colspan="1">T<sub>max</sub> (hr)</th>
<th colspan="1">t<sub>½</sub> (hr)</th>
<th colspan="1">Cl/F (mL/min/kg)</th>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 10 months-5.3 years</content>
<br/>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<linkhtml href="#footnote-1">*</linkhtml>
</td>
<td>10</td>
<td>3.0<br/>(1.0-5.9)</td>
<td>7.7<br/>(5.7-11.4)</td>
<td>3.62<br/>(2.44-5.28)</td>
</tr>
<tr>
<td>Patients taking AEDs with no known effect on the apparent clearance of lamotrigine</td>
<td>7</td>
<td>5.2<br/>(2.9-6.1)</td>
<td>19.0<br/>(12.9-27.1)</td>
<td>1.2<br/>(0.75-2.42)</td>
</tr>
<tr>
<td>Patients taking valproate only</td>
<td>8</td>
<td>2.9<br/>(1.0-6.0)</td>
<td>44.9<br/>(29.5-52.5)</td>
<td>0.47<br/>(0.23-0.77)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 5-11 years</content>
<br/>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="t16ft1"></footnoteref>
</td>
<td>7</td>
<td>1.6<br/>(1.0-3.0)</td>
<td>7.0<br/>(3.8-9.8)</td>
<td>2.54<br/>(1.35-5.58)</td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="t16ft1"></footnoteref> plus valproate</td>
<td>8</td>
<td>3.3<br/>(1.0-6.4)</td>
<td>19.1<br/>(7.0-31.2)</td>
<td>0.89<br/>(0.39-1.93)</td>
</tr>
<tr>
<td>Patients taking valproate only<linkhtml href="#footnote-2">†</linkhtml>
</td>
<td>3</td>
<td>4.5<br/>(3.0-6.0)</td>
<td>65.8<br/>(50.7-73.7)</td>
<td>0.24<br/>(0.21-0.26)</td>
</tr>
<tr>
<td>
<content stylecode="bold">Ages 13-18 years</content>
<br/>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="t16ft1"></footnoteref>
</td>
<td>11</td>
<td>
<linkhtml href="#footnote-3">‡</linkhtml>
</td>
<td>
<footnoteref idref="t16ft3"></footnoteref>
</td>
<td>1.3</td>
</tr>
<tr>
<td>Patients taking carbamazepine, phenytoin, phenobarbital, or primidone<footnoteref idref="t16ft1"></footnoteref> plus valproate</td>
<td>8</td>
<td>
<footnoteref idref="t16ft3"></footnoteref>
</td>
<td>
<footnoteref idref="t16ft3"></footnoteref>
</td>
<td>0.5</td>
</tr>
<tr>
<td>Patients taking valproate only</td>
<td>4</td>
<td>
<footnoteref idref="t16ft3"></footnoteref>
</td>
<td>
<footnoteref idref="t16ft3"></footnoteref>
</td>
<td>0.3</td>
</tr>
</tbody>
</table>